Article Details
Retrieved on: 2018-05-01 23:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Benchmark Capital</b> Advisors decreased Pfizer Inc. (PFE) stake by 9.58% reported in 2017Q4 SEC filing. <b>Benchmark Capital</b> Advisors sold 10,600 shares ... The <b>Benchmark Capital</b> Advisors holds 100,075 shares with $3.63M value, down from 110,675 last quarter. Pfizer Inc. now has $208.41B valuation.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here